Tens of thousands of dementia patients are to be enrolled in clinical trials designed to dramatically speed up the hunt for a cure, leading scientists have announced, as a second treatment was rejected for use on the NHS.
Dementia presents a rapidly growing threat to health and social care services, with soaring numbers of people affected. But despite the urgent need for cheap and effective drugs to treat the condition, only 61 patients took part in trials in the UK in 2021-22.
